img

투자전략

세계 최대 골드 관련 750개 기업 중 우리 회사의 리서치를 바탕으로
투자 기준에 부합한 200개 회사를 선정하여 고객의 투자 성향에 맞는
고수익 포트폴리오를 구성하고 실시간으로 업데이트된 기업 정보와
리스크관리를 통해 안정적이면서 고수익을 창출할 수 있는 투자전략을 제공합니다.

Portfolio

- Guiding Principles
ANNUAL RETURN
  • Generate a steady 25% return per annum
GENERATING STEADY RETURN IN THE VOLATILE SECTOR
  • Tiered portfolio strategy, tight risk management, and avoiding large losses are key to generating a steady return
PORTFOLIO STRATEGY
  • Stay disciplined and stick with the portfolio strategy
  • Portfolio strategy is designed to generating a cumulative and steady return plus selective alpha return
MANAGE RISK
  • Follow basic risk management principles
  • Focus on the five risk factors unique to bio stocks
FUNDAMENTAL RESEARCH
  • Conduct thorough fundamental research before initiating a new position
  • Understand the five key risk factors unique to bio stocks (listed next page)
MARGIN OF SAFETY
  • Strictly adhere to the margin of safety rule
VOLATILITY
  • Utilize market risk volatility as opportunities to enhance return
  • Balance price volatility between general market risk and company-specific risk

Portfolio

- Structure
OBJECTIVE Objective is to identify the alpha-generating winners through deep dive fundamental research and disciplined execution of portfolio strategy and risk management
PRIMARY FILTERING CRITERIA
  • Market cap size
  • Drug therapy field & technology
  • Leading bio institutional investor presence
  • Biotech analyst coverage
  • Catalyst & catalyst timing
~750 Nasdaq- listed BIO Companies
Identify 203 INCUBATOR stocks that deserve monitoring and deeper research
Determine
30 to 40 PAR stocks
that offer high upside potentials
Discover 15 to 20 BIRDIE stocks that will enhance portfolio diversification benefits
Top gun 3 to 5 CONVICTION stocks that will offer compelling alpha returns
Searching for Alpha
Initiate a formal research report Due diligence, identify & evaluate risk factors More due diligence, probability assessment & portfolio effect More due diligence, aim for alpha return & Exit Strategy
Note: each position %s are cost-based, not market value-based
COPYRIGHT Ⓒ 2024 써미트라이프 Inc CO., LTD. ALL RIGHTS RESERVED.
↑